Application of (Q)SAR and Expert Knowledge for ICH M7 Impurity Classification

  Рет қаралды 3,811

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
ICH M7(R1) - Chemistry and Manufacturing Control (CMC) Perspective on Hazard Assessment
20:33
ICH M7(R1) - Chemistry and Manufacturing Control (CMC) Perspective on Hazard Assessment
U.S. Food and Drug Administration
Рет қаралды 7 М.
Safety Evaluation of Drug Substance Impurities in Generics
21:51
Safety Evaluation of Drug Substance Impurities in Generics
U.S. Food and Drug Administration
Рет қаралды 2,9 М.
«Жат бауыр» телехикаясы І 30 - бөлім | Соңғы бөлім
52:59
«Жат бауыр» телехикаясы І 30 - бөлім | Соңғы бөлім
Qazaqstan TV / Қазақстан Ұлттық Арнасы
Рет қаралды 340 М.
Scary night games with Megan | Megan robot doll scared me #shorts
0:28
Scary night games with Megan | Megan robot doll scared me #shorts
One More
Рет қаралды 33 МЛН
I Sent a Subscriber to Disneyland
0:27
I Sent a Subscriber to Disneyland
MrBeast
Рет қаралды 104 МЛН
JISOO - ‘꽃(FLOWER)’ M/V
3:05
JISOO - ‘꽃(FLOWER)’ M/V
BLACKPINK
Рет қаралды 137 МЛН
Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD
28:12
Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD
U.S. Food and Drug Administration
Рет қаралды 10 М.
ICH Q11 Q&A - A Supporting Document for the Selection and Justification of Starting Materials
22:06
ICH Q11 Q&A - A Supporting Document for the Selection and Justification of Starting Materials
U.S. Food and Drug Administration
Рет қаралды 3,7 М.
FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy
36:56
FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy
U.S. Food and Drug Administration
Рет қаралды 7 М.
Mutagenic Impurities from a Drug Substance Perspective: Highlights from ICH M7 Q&A Draft Document
12:22
Mutagenic Impurities from a Drug Substance Perspective: Highlights from ICH M7 Q&A Draft Document
U.S. Food and Drug Administration
Рет қаралды 3,2 М.
Drug Substance Quality Assessment: Best Practices (23of27) Generic Drugs Forum 2018
20:18
Drug Substance Quality Assessment: Best Practices (23of27) Generic Drugs Forum 2018
U.S. Food and Drug Administration
Рет қаралды 1,5 М.
Overview of the Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs
1:22:14
Overview of the Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs
U.S. Food and Drug Administration
Рет қаралды 16 М.
Small Molecule Case Studies (8of33) Quality - Oct. 16-17, 2019
26:41
Small Molecule Case Studies (8of33) Quality - Oct. 16-17, 2019
U.S. Food and Drug Administration
Рет қаралды 513
“A Day in the Life” at FDA’s Office of Digital Transformation | Ka’Leia Graves
2:01
“A Day in the Life” at FDA’s Office of Digital Transformation | Ka’Leia Graves
U.S. Food and Drug Administration
Рет қаралды 564
We want you! Join the team at FDA’s Office of Digital Transformation (ODT)
1:55
We want you! Join the team at FDA’s Office of Digital Transformation (ODT)
U.S. Food and Drug Administration
Рет қаралды 812
FDA Clinical Investigator Training Course (CITC) 2024 - Promo Video
0:40
FDA Clinical Investigator Training Course (CITC) 2024 - Promo Video
U.S. Food and Drug Administration
Рет қаралды 304
«Жат бауыр» телехикаясы І 30 - бөлім | Соңғы бөлім
52:59
«Жат бауыр» телехикаясы І 30 - бөлім | Соңғы бөлім
Qazaqstan TV / Қазақстан Ұлттық Арнасы
Рет қаралды 340 М.